US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology market research reports and industry analysis

  2    4  5  6  7  8  9  10  
Atrium Innovations, Inc. (formerly Atrium Biotechnologies, Inc.) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Atrium Innovations, Inc. (formerly Atrium Biotechnologies, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances ...  |  read more...
USD 350
Marina Biotech, Inc. (formerly MDRNA, Inc.) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Marina Biotech, Inc. (formerly MDRNA, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...  |  read more...
USD 350
Verenium Corporation (Formerly Diversa Corporation) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Verenium Corporation (Formerly Diversa Corporation) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes ...  |  read more...
USD 350
Cytori Therapeutics, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Cytori Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Asuragen, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Asuragen, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
PolyTherics Limited : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' PolyTherics Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Life Technologies Corporation (formerly Invitrogen Corporation) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Life Technologies Corporation (formerly Invitrogen Corporation) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...  |  read more...
USD 350
Senesco Technologies, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Senesco Technologies, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Sartorius Stedim Biotech S.A. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Sartorius Stedim Biotech S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, ...  |  read more...
USD 350
ImmunoGen, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' ImmunoGen, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
AmpliPhi Biosciences Corporation (formerly Targeted Genetics Corporation) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' AmpliPhi Biosciences Corporation (formerly Targeted Genetics Corporation) Mergers & Acquisitions (M&A), Partnerships & Alliances ...  |  read more...
USD 350
Complete Genomics, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Complete Genomics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
RTI Biologics, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' RTI Biologics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Rosetta Genomics, Ltd. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Rosetta Genomics, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Albany Molecular Research, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Albany Molecular Research, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, ...  |  read more...
USD 350
Neogenix Oncology, Inc. - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... for the detection of tumor without destroying healthy cells. NOI’s lead product candidate includes Ensituximab, recognizes a particular epitope of tumor specific antigens from pancreatic or colorectal adenocarcinoma. The company also has two additional preclinical ...  |  read more...
USD 750
Exosomics Siena SpA - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... models include contract research, collaborative projects, and technological services. Exosomics provides consultancy and technical services, such as sample preparation, sample analysis and characterization, and specific training. The company works in the domains of technological development ...  |  read more...
USD 750
Advanced Cell Diagnostics, Inc. - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... RNAscope assays, spotstudio software, instruments, accessory items and automated assays. ACD offers over 3,000 pre-designed single-plex target probes. The company offers services, such as start-up assay development service, biomarker validation, custom assay development and validation, ...  |  read more...
USD 750
GlycoZym - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... Glycozym provides services related to the PTM-peptide platform which includes ready-to-use PTM-peptide arrays, and custom build PTM-peptide libraries and arrays, as well as custom designed analysis. The company uses proprietary algorithms to design, synthesize, construct, ...  |  read more...
USD 750
Biocrates Life Sciences AG - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... exchange, and storage, which can readily meet the rigorous demands of various disciplines such as life sciences, personalized medicine, clinical research, nutrition research, and pharmaceutical drug development. The company’s products include absolute IDQ P150, stero ...  |  read more...
USD 750
Celera Corporation - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... Its products include ViroSeq HIV-1 genotyping system, cystic fibrosis, HLA products, chimerism, m2000 realtime system and reagents for laboratory developed tests, among others. Celera’s products helps to predict, diagnose, monitor and treat health problems. The ...  |  read more...
USD 750
The Latest Sales Figures in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... global pharmacuetical companies to progressive biotech companies. The analysis leverages the power of BioSeeker's 1stOncology intelligence which combines company disclosed product sales and detailed drug development information. The results is not only a unique insight ...  |  read more...
USD 4,478
Biologicals in Oncology: Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of more than 137 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 547 drug targets that are included ...  |  read more...
USD 11,025
RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... drugs known to affect more than 157 specific intracellular signaling pathways for the treatment of more than 25 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding ...  |  read more...
USD 2,246
Biologicals in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... developing 1686 biological drugs in 3815 developmental projects in cancer. In addition, there are 28 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 932 drugs. Biologicals In ...  |  read more...
USD 11,246
  2    4  5  6  7  8  9  10